Theranica raised $35 mln
Theranica said March 18 that it raised $35 million in a Series B round led by aMoon. All existing investors of the company – Lightspeed Venture Partners, LionBird, Corundum Open Innovation and Takoa – participated in the round. Theranica is a bio-medical technology company developing advanced electroceuticals for migraine and other prevalent diseases.
18 March 2019•3 mins read
